1-8 of 8
Georg Lenz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Udo Holtick, Ulrike Bacher, Philipp B. Staber, Paolo Mazzeo, Corinna Leng, David Böckle, Alexander Sebastian Hölscher, Joseph Kauer, Natalia Rotter, Vladan Vucinic, Jakob D. Rudzki, David Nachbaur, Veit L. Bücklein, Ulf Schnetzke, Isabelle Krämer, Kai Wille, Alexander Hasse, Bastian von Tresckow, Mathias Hänel, Christian Koenecke, Giuliano Filippini Velazquez, Andreas Viardot, Christoph Schmid, Lorenz Thurner, Dominik Wolf, Marion Subklewe, Martin Dreyling, Peter Dreger, Sascha Dietrich, Ulrich Keller, Ulrich Jaeger, Richard Greil, Thomas Pabst, Georg Lenz, Björn Chapuy
Journal: Blood Advances
Blood Adv bloodadvances.2024014903.
https://doi.org/10.1182/bloodadvances.2024014903
Published: 2024
Includes: Supplemental data
Journal Articles

Comparison of antibody-based immunotherapeutics for malignant hematological disease in an experimental murine model

Karin Frebel, Jörn C. Albring, Anika Wohlgemuth, Christian Schwöppe, Stephan Hailfinger, Georg Lenz, Matthias Stelljes
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1934–1945.
https://doi.org/10.1182/bloodadvances.2023011647
Published: 2024
Includes: Supplemental data
Journal Articles

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears

Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, Lars Haalck, Jörg Gromoll, Stefan Schlatt, Rita Exeler, Annalen Bleckmann, Georg Lenz, Sebastian Wolf, Björn Steffen, Wolfgang E. Berdel, Christoph Schliemann, Benjamin Risse, Linus Angenendt
Journal: Blood Advances
Blood Adv (2023) 8 (1): 70–79.
https://doi.org/10.1182/bloodadvances.2023011076
Published: 2023
Includes: Supplemental data
Journal Articles

Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress

Beatriz Gomez Solsona, Heike Horn, Anja Schmitt, Wendan Xu, Philip Bucher, Aylin Heinrich, Sabrina Kalmbach, Nina Kreienkamp, Maik Franke, Florian Wimmers, Laurentz Schuhknecht, Andreas Rosenwald, Mattia Zampieri, German Ott, Georg Lenz, Klaus Schulze-Osthoff, Stephan Hailfinger
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7433–7444.
https://doi.org/10.1182/bloodadvances.2023010964
Published: 2023
Includes: Supplemental data
Journal Articles

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis

Clinical Trials & Observations
Catherine Thieblemont, Bettina Altmann, Fabian Frontzek, Loïc Renaud, Loic Chartier, Nicolas Ketterer, Christian Récher, Viola Poeschel, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haioun, Franck Morschhauser, Bertram Glass, Nicolas Mounier, Herve Tilly, Andreas Rosenwald, German Ott, Georg Lenz, Thierry Molina, Marita Ziepert, Norbert Schmitz
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3968–3977.
https://doi.org/10.1182/bloodadvances.2022008888
Published: 2023
Includes: Supplemental data
Journal Articles

Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

Clinical Trials & Observations
Andrew F. Berdel, Leo Ruhnke, Linus Angenendt, Martin Wermke, Christoph Röllig, Jan-Henrik Mikesch, Annika Scheller, Teresa Hemmerle, Mattia Matasci, Klaus Wethmar, Torsten Kessler, Mirjam Gerwing, Daniel Hescheler, Michael Schäfers, Wolfgang Hartmann, Bianca Altvater, Claudia Rossig, Martin Bornhäuser, Georg Lenz, Matthias Stelljes, Bjoern Rueter, Dario Neri, Wolfgang E. Berdel, Christoph Schliemann
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3684–3696.
https://doi.org/10.1182/bloodadvances.2021006909
Published: 2022
Includes: Supplemental data
Journal Articles

Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML

Clinical Trials & Observations
Linus Angenendt, Marius Wöste, Jan-Henrik Mikesch, Maria Francisca Arteaga, Adrian Angenendt, Sarah Sandmann, Wolfgang E. Berdel, Georg Lenz, Martin Dugas, Soheil Meshinchi, Christoph Schliemann, Claudia Rössig
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4413–4421.
https://doi.org/10.1182/bloodadvances.2021005236
Published: 2021
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Clinical Trials & Observations
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2707–2716.
https://doi.org/10.1182/bloodadvances.2020004155
Published: 2021
Includes: Supplemental data